Article Versions Notes

Watanabe M, Sato T, Umetsu A, Ogawa T, Nishikiori N, Suzuki M, Furuhashi M, Ohguro H. The Specific ROCK2 Inhibitor KD025 Alleviates Glycolysis through Modulating STAT3-, CSTA- and S1PR3-Linked Signaling in Human Trabecular Meshwork Cells. Biomedicines. 2024; 12(6):1165. https://doi.org/10.3390/biomedicines12061165

Watanabe, Megumi, Tatsuya Sato, Araya Umetsu, Toshifumi Ogawa, Nami Nishikiori, Megumi Suzuki, Masato Furuhashi, and Hiroshi Ohguro. 2024. "The Specific ROCK2 Inhibitor KD025 Alleviates Glycolysis through Modulating STAT3-, CSTA- and S1PR3-Linked Signaling in Human Trabecular Meshwork Cells" Biomedicines 12, no. 6: 1165. https://doi.org/10.3390/biomedicines12061165

Watanabe, M., Sato, T., Umetsu, A., Ogawa, T., Nishikiori, N., Suzuki, M., Furuhashi, M., & Ohguro, H. (2024). The Specific ROCK2 Inhibitor KD025 Alleviates Glycolysis through Modulating STAT3-, CSTA- and S1PR3-Linked Signaling in Human Trabecular Meshwork Cells. Biomedicines, 12(6), 1165. https://doi.org/10.3390/biomedicines12061165